STSASatsuma Pharmaceuticals, Inc. Common Stock US Stock
Open: $5.75 High: $6.52 Low: $5.56 Close: $5.9
Range: 2022-08-08 - 2022-08-09Volume:143,813
Powered by Finage Stock APIDelayed data
Satsuma Pharmaceuticals, Inc. Common Stock 400 OYSTER POINT BOULEVARD https://www.satsumarx.comSatsuma Pharmaceuticals Inc is a clinical-stage biopharmaceutical company engaged in developing a novel therapeutic product for the treatment of migraine. Its product candidate, STS101, is a drug-device combination of a dry-powder formulation of dihydroergotamine mesylate, or DHE, which can be self-administered with a pre-filled, single-use, nasal delivery device.
- Employees: 24